{"id":2817,"date":"2020-10-01T16:00:00","date_gmt":"2020-10-01T16:00:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/xvivo-perfusion-completes-the-acquisition-of-organ-assist-b-v\/"},"modified":"2020-10-01T16:00:00","modified_gmt":"2020-10-01T16:00:00","slug":"xvivo-perfusion-completes-the-acquisition-of-organ-assist-b-v","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-completes-the-acquisition-of-organ-assist-b-v\/","title":{"rendered":"XVIVO Perfusion completes the acquisition of Organ Assist B.V."},"content":{"rendered":"
\n

XVIVO Perfusion AB (publ) (\u201cXVIVO\u201d) has today completed the acquisition of all shares in the Dutch medtech company Organ Assist B.V. (\u201cOrgan Assist\u201d) that XVIVO announced on 23 September 2020.<\/strong><\/p>\n<\/div>\n

\n

On 23 September 2020, XVIVO announced that the company had entered into an agreement to acquire all shares in Organ Assist. The completion of the acquisition was conditional upon XVIVO obtaining financing for the purchase price of up to EUR 24 million through the new issue of shares that the company successfully carried out later the same day. XVIVO has today paid the initial cash purchase price of EUR 20 million and completed the acquisition of Organ Assist. Accordingly, Organ Assist will be consolidated into XVIVO as of 1 October 2020.
\u00a0
Pursuant to the share purchase agreement, two earn-out payments of up to EUR 2 million (each) may become payable depending on the achievement of sales targets in 2021 and the regulatory approval in the US for Organ Assist\u2019s kidney device, respectively.
\u00a0
For further information on the acquisition and Organ Assist, please see the press release that XVIVO published on 23\u00a0September 2020.
\u00a0
October 1, 2020
Gothenburg
XVIVO Perfusion AB (publ)<\/p>\n<\/div>\n

\n

For further information please contact:<\/strong><\/p>\n\n

Dag Andersson, CEO, +46 76 643 30 31, e-post: dag.andersson@xvivoperfusion.com<\/a>
Christoffer Rosenblad, CFO, +46 73 519 21 59 e-post: christoffer.rosenblad@xvivoperfusion.com<\/a><\/p>\n<\/div>\n

\n

About Us<\/strong><\/p>\n\n

XVIVO Perfusion AB is a medical technology company which develops solutions and systems for assessing and preserving organs outside the body and for selecting usable organs and maintaining them in optimal condition pending transplantation. The company is headquartered in Gothenburg, Sweden, and has one office in Lund, Sweden and one office in the USA. The XVIVO share is listed on Nasdaq Stockholm and has the ticker symbol XVIVO. More information can be found on the website www.xvivoperfusion.com.<\/a><\/p>\n<\/div>\n

\n

Attachments<\/strong><\/p>\n\n

XVIVO Perfusion completes the acquisition of Organ Assist B.V.<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

XVIVO Perfusion AB (publ) (\u201cXVIVO\u201d) has today completed the acquisition of all shares in the Dutch medtech company Organ Assist…<\/p>\n","protected":false},"template":"","class_list":["post-2817","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-ca","mfn-news-tag-mfn-ca-ma"],"acf":[],"yoast_head":"\nXVIVO Perfusion completes the acquisition of Organ Assist B.V. - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-completes-the-acquisition-of-organ-assist-b-v\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XVIVO Perfusion completes the acquisition of Organ Assist B.V. - XVIVO\" \/>\n<meta property=\"og:description\" content=\"XVIVO Perfusion AB (publ) (\u201cXVIVO\u201d) has today completed the acquisition of all shares in the Dutch medtech company Organ Assist...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-completes-the-acquisition-of-organ-assist-b-v\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-completes-the-acquisition-of-organ-assist-b-v\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-completes-the-acquisition-of-organ-assist-b-v\\\/\",\"name\":\"XVIVO Perfusion completes the acquisition of Organ Assist B.V. - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2020-10-01T16:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-completes-the-acquisition-of-organ-assist-b-v\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-completes-the-acquisition-of-organ-assist-b-v\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-completes-the-acquisition-of-organ-assist-b-v\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XVIVO Perfusion completes the acquisition of Organ Assist B.V.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XVIVO Perfusion completes the acquisition of Organ Assist B.V. - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-completes-the-acquisition-of-organ-assist-b-v\/","og_locale":"en_US","og_type":"article","og_title":"XVIVO Perfusion completes the acquisition of Organ Assist B.V. - XVIVO","og_description":"XVIVO Perfusion AB (publ) (\u201cXVIVO\u201d) has today completed the acquisition of all shares in the Dutch medtech company Organ Assist...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-completes-the-acquisition-of-organ-assist-b-v\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-completes-the-acquisition-of-organ-assist-b-v\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-completes-the-acquisition-of-organ-assist-b-v\/","name":"XVIVO Perfusion completes the acquisition of Organ Assist B.V. - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2020-10-01T16:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-completes-the-acquisition-of-organ-assist-b-v\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-completes-the-acquisition-of-organ-assist-b-v\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-completes-the-acquisition-of-organ-assist-b-v\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"XVIVO Perfusion completes the acquisition of Organ Assist B.V."}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2817","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2817"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}